The Brazilian experience of implementing the active pharmacovigilance of dolutegravir

In 2017, the Ministry of Health Brazilian started using dolutegravir (DTG) 50 mg to all people living with HIV who began antiretroviral therapy (ART) or rescue regimens. Although DTG is thought to have better tolerability levels and a lower possibility of causing adverse reactions, it is necessary t...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Cynthia Julia Braga, Correa, Renato Girade, Evangelista, Livia Ramalho, Fleck, Karen, Silva, Leandro, Renaud, Francoise, Vitoria, Marco, Doherty, Meg, Benzaken, Adele Schwartz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417631/
https://www.ncbi.nlm.nih.gov/pubmed/30855509
http://dx.doi.org/10.1097/MD.0000000000014828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417631/
https://www.ncbi.nlm.nih.gov/pubmed/30855509
http://dx.doi.org/10.1097/MD.0000000000014828

Ejemplares similares